Xylazine co-occurrence with illicit fentanyl is a growing threat in the Deep South: a retrospective study of decedent data

Harm Reduct J. 2024 Feb 20;21(1):46. doi: 10.1186/s12954-024-00959-2.

Abstract

Background: Xylazine is a dangerous veterinary sedative found mainly in illicit fentanyl in the Northeast and Midwest. Its role in the Deep South overdose crisis is not well-characterized.

Methods: We conducted a retrospective review of autopsy data in Jefferson County, Alabama to identify trends in xylazine prevalence among people who fatally overdosed from June 2019 through June 2023.

Results: 165 decedents met inclusion criteria. While the first identified xylazine-associated overdose was in June 2019, xylazine has become consistently prevalent since January 2021. All cases of xylazine-associated fatal overdoses were accompanied by fentanyl, and most (75.4%) involved poly-drug stimulant use. The average age was 42.2, and most decedents were white (58.8%) and male (68.5%). Overall, 18.2% of people were unhoused at the time of death.

Discussion: Xylazine is prevalent in the Deep South. Efforts to promote harm reduction, publicly viewable drug supply trends, and legalization of drug checking and syringe service programs should be prioritized.

Keywords: Fentanyl; Opioid epidemic; Opioid use disorder; Overdose; Xylazine.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analgesics, Opioid
  • Drug Overdose* / epidemiology
  • Fentanyl
  • Humans
  • Illicit Drugs*
  • Male
  • Retrospective Studies
  • Xylazine

Substances

  • Fentanyl
  • Analgesics, Opioid
  • Xylazine
  • Illicit Drugs